ANXA6 and gastric cancer: Thus, Uchihara et al. [45] found that annexin A6 in CAF-EVs plays a pivotal role in network formation and drug resistance of gastric cancer cells in the ECM via activation of β1 integrin-focal adhesion kinase (FAK)-YAP.